Three fast-growing niche players backed by Ashish Kacholia have posted over 20% profit growth—but pricey valuations raise questions. Should they be on your watchlist?

Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715, "Sun Pharma" and ...

With obesity and Type 2 diabetes on the rise, India is emerging as a key battleground for global drugmakers developing next-generation therapies targeting metabolic disorders.

Sun Pharmaceutical Industries Ltd. closed 14.78% below its 52-week high of 1,960.20 rupees, which the company achieved on ...

The Advocate highlights social inequality through original stories and opinions, and content generated by fellow NNPA and other publications ...

Cosmo today announced the signing of an agreement to sell “Digital Trust” to its existing customer Tinexta InfoCert, Europe’s largest Certification Authority and a subsidiary of Tinexta S.p.A., a ...